Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial of Inhaled N,N-Dimethyltryptamine in Patients With Partial Response in Depression.

NCT06094907 is registered in ClinicalTrials.gov with Universidade Federal do Rio Grande do Norte as lead sponsor.

NCT NCT06094907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06094907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial of Inhaled N,N-Dimethyltryptamine in Patients With Partial Response in Depression.
Lead sponsor
Universidade Federal do Rio Grande do Norte
Phase
Phase 2
Overall status
Completed
Start date
October 9, 2023
Completion date
March 30, 2024
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, unipolar, depressive disorder